---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-012516"
form_type: "8-K"
ticker: "DARE"
cik: "0001401914"
company_name: "Dare Bioscience, Inc."
filed_at: "2025-09-02T23:59:59+00:00"
generated_at: "2026-05-17T08:47:46.271734+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Daré Bioscience provides corporate presentation; no specific data disclosed

## Summary
- Presentation dated September 2, 2025 filed as exhibit; full content not included in 8-K.
- No new financial or operational details available from this filing for summary.
- Presentation intended for investor meetings; available on Daré's IR website.
- Investors should consult company website for complete presentation content.

## SEC filing metadata
- accession: 0001493152-25-012516
- form_type: 8-K
- ticker: DARE
- cik: 0001401914
- company_name: Dare Bioscience, Inc.
- filed_at: 2025-09-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1401914/000149315225012516/0001493152-25-012516-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1401914/000149315225012516/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-012516
- JSON: https://secwatch.observer/filing/0001493152-25-012516.json
- Plain text: https://secwatch.observer/filing/0001493152-25-012516.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.